These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16224741)

  • 21. In situ metabolism of levetiracetam in blood of patients with epilepsy.
    Patsalos PN; Ghattaura S; Ratnaraj N; Sander JW
    Epilepsia; 2006 Nov; 47(11):1818-21. PubMed ID: 17116020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No kinetic interaction between levetiracetam and cyclosporine: a case report.
    Franzoni E; Sarajlija J; Garone C; Malaspina E; Marchiani V
    J Child Neurol; 2007 Apr; 22(4):440-2. PubMed ID: 17621525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam in the management of epilepsy.
    Leach JP
    Hosp Med; 2004 Dec; 65(12):740-4. PubMed ID: 15624450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of levetiracetam on challenging behavior.
    Hurtado B; Koepp MJ; Sander JW; Thompson PJ
    Epilepsy Behav; 2006 May; 8(3):588-92. PubMed ID: 16473557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of levetiracetam in a patient with chronic motor tics, Rolandic epilepsy and attentional and behavioural disorder].
    Fernández-Mayoralas DM; Fernández-Jaén A; Muñoz-Jareño N; Calleja-Pérez B; Arroyo-González R
    Rev Neurol; 2009 Nov 1-15; 49(9):502-3. PubMed ID: 19859894
    [No Abstract]   [Full Text] [Related]  

  • 27. Conclusions of the available meta-analyses exploring the efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2011 May; 38(3):388-9. PubMed ID: 21515492
    [No Abstract]   [Full Text] [Related]  

  • 28. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levetiracetam (keppra) in epileptology].
    Kalinin VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):74-7. PubMed ID: 18683359
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam prophylaxis in pediatric migraine--an open-label study.
    Pakalnis A; Kring D; Meier L
    Headache; 2007 Mar; 47(3):427-30. PubMed ID: 17371359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label trial of levetiracetam for treatment of cervical dystonia.
    Tarsy D; Ryan RK; Ro SI
    Mov Disord; 2006 May; 21(5):734-5. PubMed ID: 16570301
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of Holmes tremor by levetiracetam.
    Ferlazzo E; Morgante F; Rizzo V; Sciarrone G; Meduri M; Magaudda A; Girlanda P; Quartarone A
    Mov Disord; 2008 Oct; 23(14):2101-3. PubMed ID: 18785235
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F; Ozcay F; Haberal M
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
    Lay-Son Rivas L; Pizarro Segura J; Meza Flores R
    Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909
    [No Abstract]   [Full Text] [Related]  

  • 40. Dramatic weight loss with levetiracetam.
    Gelisse P; Juntas-Morales R; Genton P; Hillaire-Buys D; Diaz O; Coubes P; Crespel A
    Epilepsia; 2008 Feb; 49(2):308-15. PubMed ID: 17825078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.